ClinicalTrials.gov
public full text
Public Domain
A Phase I, Open-Label, Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide in Healthy Chinese Participants
A Phase I, single centre, open-label study to investigate the pharmacokinetics (PK), safety and tolerability of single and multiple twice daily doses of inhaled Aclidinium Bromide in healthy Chinese male and female subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Nebulized Bronchodilators on Heart Rate#1111712
- Study of Danirixin in Japanese Healthy Elderly Male Subjects#1075800
- Pharmacokinetic Study of Lansoprazole Capsules in Healthy Chinese Volunteer#836759
- A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants#910761
- A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects#902147
Record · ID 1102508
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive